A Study of LY2157299 Monohydrate in Healthy Volunteers
Status: | Completed |
---|---|
Conditions: | Healthy Studies |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | Any |
Updated: | 2/4/2013 |
Start Date: | January 2013 |
End Date: | February 2013 |
Contact: | This is a single site clinical trial. 1-877-CTLILLY (1-877-285-4559) or |
Phone: | 1-317-615-4559 |
Disposition of [14C]-LY2157299 Monohydrate Following Oral Administration in Healthy Subjects
This study involves a single dose of 150 milligram (mg) of radiolabeled LY2157299
monohydrate in healthy participants. The study will determine how the body eliminates the
radioactivity and LY2157299 monohydrate. Participants must be healthy surgically sterile or
postmenopausal females, or sterile males. This study is approximately 8 to 15 days.
Inclusion Criteria:
- Healthy surgically sterile females, postmenopausal females, or sterile males
- Body mass index (BMI) of 18.5 to 32.0 kilograms per square meter (kg/m^2)
- Have venous access sufficient to allow for blood sampling
Exclusion Criteria:
- Have known allergies to LY2157299, related compounds or any components of the
formulation
- Have an abnormal blood pressure as determined by the investigator
- Have participated in a [^14C]-study within the last 6 months prior to admission for
this study
We found this trial at
1
site
Click here to add this to my saved trials